List of Tables
Table 1. Cystic Fibrosis (CF) Therapeutics Market Trends
Table 2. Cystic Fibrosis (CF) Therapeutics Market Drivers & Opportunity
Table 3. Cystic Fibrosis (CF) Therapeutics Market Challenges
Table 4. Cystic Fibrosis (CF) Therapeutics Market Restraints
Table 5. Global Cystic Fibrosis (CF) Therapeutics Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Cystic Fibrosis (CF) Therapeutics Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cystic Fibrosis (CF) Therapeutics Product Type
Table 9. Key Companies Time to Begin Mass Production of Cystic Fibrosis (CF) Therapeutics
Table 10. Global Cystic Fibrosis (CF) Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis (CF) Therapeutics as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Cystic Fibrosis (CF) Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Cystic Fibrosis (CF) Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Cystic Fibrosis (CF) Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Cystic Fibrosis (CF) Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Region (2019-2024) & (%)
Table 27. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Cystic Fibrosis (CF) Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Cystic Fibrosis (CF) Therapeutics Sales Value, (2025-2030) & (US$ Million)
Table 31. Vertex Pharmaceuticalsorporated Basic Information List
Table 32. Vertex Pharmaceuticalsorporated Description and Business Overview
Table 33. Vertex Pharmaceuticalsorporated Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Vertex Pharmaceuticalsorporated (2019-2024)
Table 35. Vertex Pharmaceuticalsorporated Recent Developments
Table 36. Gilead Basic Information List
Table 37. Gilead Description and Business Overview
Table 38. Gilead Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Gilead (2019-2024)
Table 40. Gilead Recent Developments
Table 41. AbbVie, Basic Information List
Table 42. AbbVie, Description and Business Overview
Table 43. AbbVie, Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of AbbVie, (2019-2024)
Table 45. AbbVie, Recent Developments
Table 46. Novartis AG Basic Information List
Table 47. Novartis AG Description and Business Overview
Table 48. Novartis AG Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Novartis AG (2019-2024)
Table 50. Novartis AG Recent Developments
Table 51. F. Hoffmann-La Roche Ltd Basic Information List
Table 52. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 53. F. Hoffmann-La Roche Ltd Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of F. Hoffmann-La Roche Ltd (2019-2024)
Table 55. F. Hoffmann-La Roche Ltd Recent Developments
Table 56. Alaxia Basic Information List
Table 57. Alaxia Description and Business Overview
Table 58. Alaxia Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Alaxia (2019-2024)
Table 60. Alaxia Recent Developments
Table 61. Merck & Co. Basic Information List
Table 62. Merck & Co. Description and Business Overview
Table 63. Merck & Co. Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Merck & Co. (2019-2024)
Table 65. Merck & Co. Recent Developments
Table 66. AIT (Advanced Inhalation Therapies) Basic Information List
Table 67. AIT (Advanced Inhalation Therapies) Description and Business Overview
Table 68. AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of AIT (Advanced Inhalation Therapies) (2019-2024)
Table 70. AIT (Advanced Inhalation Therapies) Recent Developments
Table 71. ALLERGAN Basic Information List
Table 72. ALLERGAN Description and Business Overview
Table 73. ALLERGAN Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of ALLERGAN (2019-2024)
Table 75. ALLERGAN Recent Developments
Table 76. AstraZeneca Basic Information List
Table 77. AstraZeneca Description and Business Overview
Table 78. AstraZeneca Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of AstraZeneca (2019-2024)
Table 80. AstraZeneca Recent Developments
Table 81. Teva Pharmaceutical Industries Ltd Basic Information List
Table 82. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 83. Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Teva Pharmaceutical Industries Ltd (2019-2024)
Table 85. Teva Pharmaceutical Industries Ltd Recent Developments
Table 86. Alcresta Basic Information List
Table 87. Alcresta Description and Business Overview
Table 88. Alcresta Cystic Fibrosis (CF) Therapeutics Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cystic Fibrosis (CF) Therapeutics Business of Alcresta (2019-2024)
Table 90. Alcresta Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Cystic Fibrosis (CF) Therapeutics Downstream Customers
Table 94. Cystic Fibrosis (CF) Therapeutics Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cystic Fibrosis (CF) Therapeutics Product Picture
Figure 2. Global Cystic Fibrosis (CF) Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cystic Fibrosis (CF) Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 4. Cystic Fibrosis (CF) Therapeutics Report Years Considered
Figure 5. Global Cystic Fibrosis (CF) Therapeutics Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Cystic Fibrosis (CF) Therapeutics Revenue in 2023
Figure 7. Cystic Fibrosis (CF) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Pancreatic enzyme supplements Picture
Figure 9. Mucolytics Picture
Figure 10. Bronchodilators Picture
Figure 11. CFTR modulators Picture
Figure 12. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Cystic Fibrosis (CF) Therapeutics Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Oral drugs
Figure 15. Product Picture of Inhaled drugs
Figure 16. Global Cystic Fibrosis (CF) Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Cystic Fibrosis (CF) Therapeutics Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Cystic Fibrosis (CF) Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Cystic Fibrosis (CF) Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Cystic Fibrosis (CF) Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Cystic Fibrosis (CF) Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Cystic Fibrosis (CF) Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Cystic Fibrosis (CF) Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Cystic Fibrosis (CF) Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Cystic Fibrosis (CF) Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Cystic Fibrosis (CF) Therapeutics Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Cystic Fibrosis (CF) Therapeutics Sales Value (%), (2019-2030)
Figure 29. United States Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 35. China Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 37. China Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 47. India Cystic Fibrosis (CF) Therapeutics Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Cystic Fibrosis (CF) Therapeutics Sales Value by Type (%), 2023 VS 2030
Figure 49. India Cystic Fibrosis (CF) Therapeutics Sales Value by Application (%), 2023 VS 2030
Figure 50. Cystic Fibrosis (CF) Therapeutics Industrial Chain
Figure 51. Cystic Fibrosis (CF) Therapeutics Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
